NCT01833013

Brief Summary

Nowadays, one in six couples consults for fertility problems. If the standard examination and tests do not reveal any cause of infertility, the woman may undergo a laparoscopic exploration which reveals endometriosis in more than 50% of cases. Endometriosis is an inflammatory disease defined as the presence of endometrial tissue out of the uterine cavity. It is frequent (1 in 10 women) and associated with a high economic burden (22 billion dollars in 2002 in the USA) and important decrease in quality of life. Physiopathological mechanisms and risk factors for endometriosis are not well identified. A woman with endometriosis is 20 times more at risk of infertility. Fecundity rate of a 25-year-old couple is about 15 to 20% in the general population and only 2 to 10% in case of endometriosis. There are many manifestations of this disease (infertility, pelvic pain) and the anatomo-clinical correlation is not good. The presently used international classification (American Fertility Society revised in 1985, AFSr) does not predict the chance of pregnancy. New scores such as the Endometriosis Fertility Index (EFI) have been proposed to do so, but need to be validated. Treatment for endometriosis-related infertility is not consensual. A prospective cohort study would give access to clinical data of patients followed in our center, so as to identify clinical factors predicting pregnancy and to help treatment decision for women with endometriosis suffering from infertility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 16, 2013

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

January 9, 2015

Status Verified

April 1, 2013

Enrollment Period

5 years

First QC Date

April 11, 2013

Last Update Submit

January 8, 2015

Conditions

Keywords

EndometriosisCohort studyfertilitypregnancyassisted reproductive technicslaparoscopy

Outcome Measures

Primary Outcomes (1)

  • live birth date

    Assessment of the number of live birth in the 3 years following the laparoscopic exploration making the diagnosis of endometriosis

    3 years

Secondary Outcomes (2)

  • Quality of life

    3 years

  • pain symptoms

    3 years

Study Arms (1)

endometriosis cohort

OTHER

females suffer from endometriosis

Other: live birth date and quality of life assessment

Interventions

Eligibility Criteria

Age18 Years - 41 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Woman from 18 to 41 years old.
  • Dealing with infertility,
  • With a normal pelvic echography and hysterosalpingography, a normal hormonal status and a partner with a normal sperm.
  • For whom a laparoscopic exploration finds endometriosis.
  • Consenting to participate to the study.

You may not qualify if:

  • Any contraindication for general anesthesia or for laparoscopy.
  • Any contraindication for pregnancy.
  • Follow-up is impossible.
  • Consent is impossible.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Montpellier

Montpellier, Herault, 34295, France

RECRUITING

MeSH Terms

Conditions

EndometriosisInfertility

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Herve Dechaud, MD,PhD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Herve Dechaud, MD,PhD

CONTACT

claire chauveton, pharmD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2013

First Posted

April 16, 2013

Study Start

April 1, 2013

Primary Completion

April 1, 2018

Study Completion

October 1, 2018

Last Updated

January 9, 2015

Record last verified: 2013-04

Locations